Source: Health Products Regulatory Authority (IE) Revision Year: 2015 Publisher: Fresenius AG, 61343 BAD Homburg v.d.H., Germany
Dipeptiven, concentrate for solution for infusion.
| Pharmaceutical Form |
|---|
|
Concentrate for solution for infusion. A clear colourless solution. |
1 ml contains:
Active substance: N(2)-L-alanyl-L-glutamine
Quantity: 200 mg (= 82.0 mg L-alanine, 134.6 mg L-glutamine)
theoretical osmolarity: 921 mosmol/l
titration acidity: 90–105 mmol NaOH/l
pH value: 5.4-6.0
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Alanine glutamine dipeptide |
N(2)-L-alanyl-L-glutamine is rapidly split into alanine and glutamine after infusion, which are useful amino acids for the body in dealing with hypercatabolic and/or hypermetabolic conditions. |
| List of Excipients |
|---|
|
Water for injection |
Glass bottles.
1 × 50 ml, 10 × 50 ml
1 × 100 ml, 10 × 100 ml
Type II, colourless glass.
Rubber closure.
Not all pack sizes may be marketed.
Fresenius AG, 61343 BAD Homburg v.d.H., Germany
PA 697/2/1
Date of first authorisation: 20 May 1996
Date of last renewal: 29 March 2010
| Drug | Countries | |
|---|---|---|
| DIPEPTIVEN | Austria, Brazil, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
